Vol. 27, Issue 1, 2017December 01, 2017 PDT
CAUSATION PRINCIPLES IN PHARMACEUTICAL ANTITRUST LITIGATION
CAUSATION PRINCIPLES IN PHARMACEUTICAL ANTITRUST LITIGATION
Steve D. Shadowen,
Articles in Vol. 27, Issue 1, 2017
Vol. 27, Issue 1, 2017
- WHERE ART THOU, EFFICIENCIES? THE UNCERTAIN ROLE OF EFFICIENCIES IN MERGER REVIEWKaley FendallDavid Maas
- CERTIFICATES OF PUBLIC ADVANTAGE: BYPASSING THE FTC IN HEALTHCARE MERGERS?Lisl Dunlop
- DIGITAL HEALTH PRIVACY: OLD LAWS MEET NEW TECHNOLOGIESReece HirschJenny Harrison
- CAUSATION PRINCIPLES IN PHARMACEUTICAL ANTITRUST LITIGATIONSteve D. Shadowen
- ANTITRUST’S HIDDEN HOOK IN DRUG PRICE INCREASESMichael A. Carrier
- EMPIRICAL EVIDENCE OF DRUG COMPANIES USING CITIZEN PETITIONS TO HOLD OFF COMPETITIONRobin FeldmanJohn GrayGiora Ashkenazi
- THE EFFICIENCIES DEFENESTRATION: ARE REGULATORS THROWING VALID HEALTHCARE EFFICIENCIES OUT THE WINDOW?Kyle QuackenbushRonnie SolomonJacob Snow
- WHAT PAST AGENCY ACTIONS SAY ABOUT COMPLEXITY IN MERGER REMEDIES, WITH AN APPLICATION TO GENERIC DRUG DIVESTITURESThomas D. JeitschkoArthur ZhouEric Emch
- RETHINKING HEALTHCARE DATA BREACH LITIGATIONJay EdelsonAaron Lawson
- THE PROXIMATE CAUSE REQUIREMENT IN PRIVATE REVERSE PAYMENT ANTITRUST LITIGATIONKenneth R. O’RourkeSarah H. Trela
- UNCERTAINTY AND SCIENTIFIC COMPLEXITY: AN INTRODUCTION TO ECONOMIC FORCES THAT DRIVE CURRENT DEBATES IN HEALTHCARE ANTITRUSTPaul Wong, Ph.D.
Steve D. Shadowen, CAUSATION PRINCIPLES IN PHARMACEUTICAL ANTITRUST LITIGATION, 27 Competition Journal (2017).